Myovista ETX is a combination formulation developed to support the management of musculoskeletal conditions associated with muscle spasm, inflammation, and pain.
The dual-action softgel formulation assists healthcare professionals in addressing inflammatory discomfort along with muscle stiffness, helping improve mobility and functional recovery during physician-directed therapy.
Category : Tablets & Capsules
Get a QuoteDescription
Myovista ETX combines Thiocolchicoside, a muscle relaxant, with Etoricoxib, a selective COX-2 inhibitor, providing complementary mechanisms for musculoskeletal care.
Thiocolchicoside acts on muscle receptors to help reduce muscle spasm and stiffness associated with painful musculoskeletal conditions.
Etoricoxib selectively inhibits the cyclooxygenase-2 (COX-2) enzyme involved in inflammatory prostaglandin synthesis, supporting reduction of inflammation and pain signaling.
The combination is designed to assist in relieving muscle-related discomfort while supporting patient mobility under medical supervision.
Composition
Thiocolchicoside 4 mg + Etoricoxib 60 mg Capsules (Softgel)
Intended Use
Treatment should be based on clinical evaluation and prescribed by a registered healthcare professional.
| Property | Details |
|---|---|
| Dosage Form: | Softgel Capsule |
| Therapeutic Category: | Muscle Relaxant & Anti-Inflammatory Combination |
| Pack Size: | 10 × 1 × 10 Blister |
| Route of Administration: | Oral |
| Brand: | Servochem |
